首页 | 官方网站   微博 | 高级检索  
     

红花注射液对急性冠脉综合征患者炎症反应的影响
引用本文:张焕鑫,张宏考,肖俊会,高宇勤,刘秋莎.红花注射液对急性冠脉综合征患者炎症反应的影响[J].中国医药导报,2011,8(35):86-87.
作者姓名:张焕鑫  张宏考  肖俊会  高宇勤  刘秋莎
作者单位:湖北医药学院附属人民医院心内科,湖北十堰,442000
摘    要:目的:探讨红花注射液对急性冠脉综合征患者血浆炎症因子的影响。方法:将60例患者随机分为红花组及对照组,在治疗前及治疗15 d后,抽取静脉血,检测超敏C反应蛋白(hs-CRP)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和同型半胱氨酸(Hcy)的浓度。结果:红花组与对照组在治疗15 d后,血浆hs-CRP、IL-6、TNF-α和Hcy水平均较治疗前明显下降,差异有统计学意义(P〈0.05)。与对照组治疗后hs-CRP、IL-6、TNF-α和Hcy水平(18.83±2.02)mg/L、(29.42±6.25)pg/ml、(61.27±12.54)fmol/L、(6.13±1.24)μmol/L]比较,红花组(6.58±1.73)mg/L、(20.13±7.46)pg/ml、(41.85±9.78)fmol/L、(4.56±1.17)μmol/L]下降更明显(P〈0.05)。结论:常规治疗基础上加用红花注射液可降低急性冠脉综合征患者血浆超敏C反应蛋白、白介素-6、肿瘤坏死因子-α和同型半胱氨酸的水平,抑制炎症反应。

关 键 词:红花注射液  急性冠脉综合征  炎症反应

Effect of Safflower Injection on inflammation reaction in patients with acute coronary syndrome
ZHANG Huanxin,ZHANG Hongkao,XIAO Junhui,GAO Yuqin,LIU Qiusha.Effect of Safflower Injection on inflammation reaction in patients with acute coronary syndrome[J].China Medical Herald,2011,8(35):86-87.
Authors:ZHANG Huanxin  ZHANG Hongkao  XIAO Junhui  GAO Yuqin  LIU Qiusha
Affiliation:ZHANG Huanxin,ZHANG Hongkao,XIAO Junhui,GAO Yuqin,LIU Qiusha Department of Cardiovascular,the People's Hospital Affiliated to Hubei Medical University,Hubei Province,Shiyan 442000,China
Abstract:Objective: To study the effects of Safflower Injection on plasma level of inflammatory factor in patients with acute coronary syndrome(ACS).Methods: 60 patients with ACS were randomly divided into Safflower group and control group,and the concentration of high sensitive C reaction protein(hs-CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α) and homocysteine(Hcy) were detected before the treatment and 15 days after the treatment.Results: After treatment for 15 days,the contents of hs-CRP,IL-6,TNF-α and Hcy were decreased obviously in Safflower group and control group compared with before treatment,the differences were significant(P0.05).Compared with the level of hs-CRP,IL-6,TNF-α and Hcy after treatment in the control group (18.83±2.02) mg/L,(29.42±6.25) pg/ml,(61.27±12.54) fmol/L,(6.13±1.24) μmol/L],the variations were more obvious in Safflower group (6.58±1.73) mg/L,(20.13±7.46) pg/ml,(41.85±9.78) fmol/L,(4.56±1.17) μmol/L](P0.05).Conclusion: The normal regulation treatment adding Safflower Injection can decrease the levels of hs-CRP,IL-6,TNF-α and Hcy in the patients with acute coronary syndrome,thus inhibiting inflammatory reaction.
Keywords:Safflower Injection  Acute coronary syndrome  Inflammation reaction  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号